BBIO icon

BridgeBio Pharma

354 hedge funds and large institutions have $8.13B invested in BridgeBio Pharma in 2025 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 135 increasing their positions, 102 reducing their positions, and 33 closing their positions.

Holders
354
Holders Change
+52
Holders Change %
+17.22%
% of All Funds
4.75%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.23%
New
91
Increased
135
Reduced
102
Closed
33
Calls
$388M
Puts
$79.7M
Net Calls
+$308M
Net Calls Change
-$83.4M
Name Market Value Shares Shares
Change
Shares
Change %
KAM
376
Kazazian Asset Management
Florida
-11,840 Closed
C
377
Certuity
Florida
-8,500 Closed
JGC
378
J. Goldman & Co
New York
-6,750 Closed
LP
379
LMR Partners
United Kingdom
-4,492 Closed
CCM
380
Coldstream Capital Management
Washington
-965 Closed
SSG
381
Summit Securities Group
New York
-383 Closed
BTI
382
Blue Trust Inc
Georgia
-359 Closed
SW
383
SVB Wealth
Massachusetts
-125 Closed
SC
384
Stephens Consulting
Michigan
-40 Closed
TPCW
385
TD Private Client Wealth
New York
-31 Closed
WWM
386
Wolff Wiese Magana
California
-27 Closed
GFPC
387
Global Financial Private Client
Florida
-20 Closed
CFD
388
Creative Financial Designs
Indiana
-16 Closed
WAM
389
Weiss Asset Management
Massachusetts
-1 Closed
DP
390
Diadema Partners
New Jersey
SB
391
SIG Brokerage
New York
CSS
392
Cubist Systematic Strategies
Connecticut
Squarepoint
393
Squarepoint
New York
Simplex Trading
394
Simplex Trading
Illinois
CFM
395
Crawford Fund Management
Massachusetts
CM
396
Caption Management
Oklahoma
WAM
397
Wolverine Asset Management
Illinois
PAP
398
Persistent Asset Partners
Hong Kong
Nomura Asset Management
399
Nomura Asset Management
Japan